Breakthrough pain relief with Matrifen® from Nycomed

The breakthrough pain relief patch Matrifen® is a transdermal fentanyl patch from Nycomed. The patch is indicated for patients with severe chronic pain such as cancer pain or low back pain.

The breakthrough pain relief patch Matrifen®  gives effective pain relief for patients with cancer as well as non cancer pains.

>> Information on  breakthrough pain relief

The breakthrough pain patch Matrifen® is a transdermal fentanyl patch for patients with chronic pain such as naturopathic pain, cancer pain, low back pain, nociceptive pain and other chronic pains.

Matrifen®’s advanced transdermal breakthrough pain therapy gives 3 day pain relief equal to that of other matrix fentanyl patches, but with a lower drug load, meaning a  higher degree of safety and a low environmental low environmental burden.

About Nycomed
Nycomed is a young company with a long history. Founded in 1874 in Norway by Morten Nyegaard, the company gradually began to expand into Europe, forming a strong position initially in the Nordic countries.

The modern story really begins in 1999, when Nycomed was established as a European company with a focus on sourcing and developing new pharmaceutical products. With this in place, the pace of this market expansion increased and the company now operates throughout Europe.

Transdermal fentanyl | Peripheral diabetic neuropathy | Treatment of pain